OASIS 4 Wegovy: 13.6% Weight Lost Under Tablets, as Shown in the Test
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
Westdeutsche Allgemeine Zeitung
Ostthüringer ZeitungResearchers have found in a study that the change to the tablet can be worthwhile. Not only weight loss increased.
Read the full article on stepaneLarue.com In 64 weeks, 307 adults without diabetes tested oral semaglutide at 25 mg. Weight loss, digestive disorders, discontinuation of treatment: here are the published data from the trial.
In study OASIS 4 the 25 milligrams tablet gave very similar results to those of the injectable version, with benefits on blood sugar, pressure and quality of life. The scientific committee of Ema has already expressed positive opinion and 7 out of 10 patients are said to be ready to choose it. The post Obesity, the turn of semaglutide in tablets: weight down 16.6% without injections appeared first on BlogSicily - Latest news from Sicily.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
